|
SLU7 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.37480035636395E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.95270000169501E-09 |
| Normal-vs-Stage2 |
2.16839999999108E-05 |
| Normal-vs-Stage3 |
4.32540003814097E-10 |
| Normal-vs-Stage4 |
2.00329997035453E-09 |
| Stage1-vs-Stage2 |
8.618000E-01 |
| Stage1-vs-Stage3 |
2.885200E-01 |
| Stage1-vs-Stage4 |
1.410640E-01 |
| Stage2-vs-Stage3 |
3.784800E-01 |
| Stage2-vs-Stage4 |
2.531400E-01 |
| Stage3-vs-Stage4 |
6.677800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.93209892529467E-11 |
| Normal-vs-AfricanAmerican |
9.998900E-04 |
| Normal-vs-Asian |
1.61127999999122E-05 |
| Caucasian-vs-AfricanAmerican |
4.093600E-01 |
| Caucasian-vs-Asian |
4.667600E-01 |
| AfricanAmerican-vs-Asian |
8.084200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.92500015927521E-10 |
| Normal-vs-Female |
2.80069967217855E-10 |
| Male-vs-Female |
2.001000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.07249999886849E-08 |
| Normal-vs-Age(41-60Yrs) |
3.91830001778004E-09 |
| Normal-vs-Age(61-80Yrs) |
4.62639926368524E-11 |
| Normal-vs-Age(81-100Yrs) |
7.402800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.466600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.612390E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.419800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.545640E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.562600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.145000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.140100E-02 |
| Classical-VS-Follicular |
1.523370E-01 |
| Classical-VS-Other |
1.258180E-01 |
| Classical-VS-Normal |
2.28440000249464E-09 |
| Tall-VS-Follicular |
5.350200E-01 |
| Tall-VS-Other |
6.325800E-01 |
| Tall-VS-Normal |
1.54729999923831E-08 |
| Follicular-VS-Other |
4.396600E-01 |
| Follicular-VS-Normal |
1.05060000032964E-07 |
| Other-VS-Normal |
9.402200E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.63019963983891E-10 |
| Normal-vs-N1 |
3.20560000766079E-09 |
| N0-vs-N1 |
1.786370E-01 |
|
|
